Satellos Bioscience MSLE
NASDAQ MSLE
$8.51 +0.03 (+0.41%)
As of: Oct 1, 2026 · 3:51 PM EDT

Satellos Bioscience (MSLE) Depreciation & Amortization (CF) (2025 - 2026)

Updated

Satellos Bioscience's Depreciation & Amortization (CF) came in at $1,000 for the quarter ended Jun 30, 2026, unchanged from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Satellos Bioscience reported Depreciation & Amortization (CF) of $3,000; for the year ended Dec 31, 2025, it was $4,000, down 73.3% from the prior year.

  • Going back by year, Depreciation & Amortization (CF) was $15,000 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Satellos Bioscience 131.40 Mn 131.40 Mn - 1,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1,000.00
Mar 31, 2026 1,000.00
Mar 31, 2025 1,000.00
API Access

Satellos Bioscience Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=MSLE&period=max&api_key=YOUR_API_KEY